Search For "dgci"
DCGI gives emergency use authorisation to COVID-19 vaccine Corbevax for 12
Updated : 4 years, 3 months ago IST
New Delhi [India], February 21 (ANI): Hyderabad-based pharmaceutical company Biological E on Monday received emergency use authorisation from Drugs Controller General of India (DCGI) for its COVID-19 vaccine Corbevax for the 12 to 18 age group.
Read More
SEC recommends regular market approval to Covaxin, Covishield for adults
Updated : 4 years, 4 months ago IST
New Delhi [India], January 19 (ANI): The Drugs Controller General of India's (DCGI) subject expert committee (SEC) has recommended the regular market approval to Serum Institute of India and Bharat Biotech for their COVID-19 vaccines Covaxin and Covishield with conditions for the adult po
Read More
SEC recommends emergency use authorization of Covovax, Corbevax vaccines f
Updated : 4 years, 4 months ago IST
New Delhi [India], December 28 (ANI): After reviewing all applications and data, the Subject Expert Committee (SEC), a body under India's drug regulator, has recommended granting the Emergency Use Authorization (EUA) to Serum Institute of India's COVID-19 vaccine Covovax and Corbevax vacc
Read More
Approval to Covaxin for children aged between 2-18 years awaited after eva
Updated : 4 years, 7 months ago IST
New Delhi [India], October 12 (ANI): After the evaluation of data Covaxin is yet to get approval by the Drugs Controller General of India (DCGI) for children between 2-18 years old, according to official sources.
Read More
Zydus Cadila vaccine to be inoculated through applicator, not injection, s
Updated : 4 years, 7 months ago IST
New Delhi [India], October 7 (ANI): Following the approval of the Zydus Cadila vaccine by the Drugs Controller General of India (DGCI) for emergency use, Dr VK Paul, Member (Health) of Niti Aayog on Thursday said that the vaccine will be administered through an applicator which will be us
Read More
Discussion on pricing of Zydus Cadila's COVID-19 vaccine going on, decisio
Updated : 4 years, 8 months ago IST
New Delhi [India], September 14 (ANI): The discussion on the pricing of Zydus Cadila's COVID-19 vaccine ZyCoV-D is underway, said Dr VK Paul, Member (Health) NITI Aayog on Tuesday.
Read More
Cipla seeks DCGI nod for import of Moderna's COVID-19 vaccine: Sources
Updated : 4 years, 10 months ago IST
New Delhi [India], June 29 (ANI): The Mumbai-based pharmaceutical multinational Cipla, on behalf of the US pharma major Moderna, has requested for import and marketing authorisation of its COVID-19 vaccines.
Read More
DCGI likely to approve phase 3 trial data of Covaxin on Tuesday
Updated : 4 years, 11 months ago IST
New Delhi [India], June 22 (ANI): The Drugs Controller General of India (DCGI) is likely to approve Phase III trial data of Covaxin on Tuesday, sources said.
Read More
DGCI approves emergency use of Zydus's Virafin in treating moderate COVID-
Updated : 5 years, 1 month ago IST
New Delhi [India], April 23 (ANI): Zydus Cadila received emergency use approval from the Drugs Controller General of India (DGCI) on Friday for the use of 'Virafin', Pegylated Interferon alpha-2b (PegIFN) in treating moderate COVID-19 infection in adults.
Read More
Zydus' Virafin gets emergency use approval for treating moderate COVID-19
Updated : 5 years, 1 month ago IST
New Delhi [India], April 23 (ANI): The Drugs Controller General of India (DGCI) has approved emergency use for Zydus Cadila's Pegylated Interferon alpha-2b, 'Virafin' for treating moderate COVID-19 infection in adults.
Read More
Shortage of Remdesivir doses in K'taka hospitals, DGCI to soon provide sup
Updated : 5 years, 1 month ago IST
Bengaluru (Karnataka) [India], April 14 (ANI): Private Hospitals and Nursing Homes Association's (PHANA) executive committee member Dr Rajashekar on Wednesday admitted that there was a shortage of Remdesivir doses for COVID-19 treatment and that the Drug Controller General of India (DGCI) ha
Read More
Zydus Cadila seeks DCGI nod for using its hepatitis drug for COVID-19 trea
Updated : 5 years, 1 month ago IST
New Delhi (India) [India], April 5 (ANI): Pharmaceutical Company Zydus Cadila on Monday informed that it has sought approval of the Drugs Controller General of India (DGCI) for using its hepatitis drug for the treatment of coronavirus.
Read More